Sacubitril/valsartan (LCZ696)
Kwaliteit
ISO Gecertificeerd
Levering
24-48 uur
Technische Specificaties
936623-90-4
Sacubitril, Valsartan
C12864-5mg
Apoptosis related
Apoptosis
[Na+].[Na+].[Na+].CCCCC (=O) N (CC1=CC=C (C=C1) C2=CC=CC=C2C3=NN=N[NH]3) C (C (C) C) C (O) =O.CCOC (=O) C (C) CC (CC4=CC=C (C=C4) C5=CC=CC=C5) NC (=O) CCC (O) =O
C24H29N5O3.C24H29NO5.5/2H2O.3Na
Sacubitril/valsartan (LCZ696, Sacubitril, Valsartan), consisting of valsartan and sacubitril in 1:1 molar ratio, is an orally bioavailable, dual-acting angiotensin receptor-neprilysin inhibitor (ARNi) for hypertension and heart failure. Phase 3.
2 years -80 in solvent
Beschrijving
Sacubitril/valsartan (LCZ696) Beschikbaar in 5 mg. Wordt geleverd met droogijs. Bestel eenvoudig online met snelle levering.
Specificaties
Recent bekeken producten
ExactaCruz® Pipette Tip Reload System, 50-1250 μl, case
sc-201714
80 Racks/Case
Disc Membrane Hydrophobic PTFE, 0.22μm
CPTB14222
50 PCS
Rat Serum Albumin
CSB-NP000101r-01
1 mg
Denhardt's Solution (50X)
EC-915
50 mL
FKBP4, ID (FK506-binding Protein 4, Peptidyl-prolyl cis-trans Isomerase FKBP4, PPIase FKBP4, Rotamase, HSP-binding Immunophilin, HBI, FKBP52 Protein, 52kD FK506-binding Protein, 52kD FKBP, FKBP-52, 59kD Immunophilin, FKBP59, p59 Protein, FKBP-4, FKBP52)
MBS623609-01
0.2 mL
West Nile Virus, NS3 Protease (WNV)
MBS603723-01
0.1 mg
Human Sertoli Cell Complete Medium
MBS2576755-01
100 mL
Urobilinogen protein
MBS5303823-01
100 mg
Recent gezochte producten
ExactaCruz® Pipette Tip Reload System, 50-1250 μl, case
sc-201714
80 Racks/Case
Cbp 3'UTR Luciferase Stable Cell Line
TU201714
1.0 mL
Mouse Gpx2 activation kit by CRISPRa
GA201714
1 Kit
CCDC50 Human qPCR Template Standard (NM_174908)
HK201714
1 Kit
Prpsap2 Mouse qPCR Template Standard (NM_144806)
MK201714
1 Kit
Horse Prekallikrein Affinity Purified
B2017141
50 µg
Human Recombinant Activin A
B2017149
10 µg
Mouse Alpha-N-acetyl-neuraminyl-2, 3-beta-galactosyl-1, 3-N-acetyl-galactosaminide alpha-2, 6-sialyltransferase (ST6GALNAC4) ELISA Kit
MBS7201714-01
48 Well